The Schall Law Firm Urges Investor Participation In An Inquiry Into Bank OZK For Securities Related Infractions

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bank OZK ("Bank OZK" or "the Company") (NASDAQ:OZK) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or […]

4D Molecular Therapeutics Inc Is Being Investigated For Possible Securities Fraud And The Schall Law Firm Urges Impacted Investors To Reach Out

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics" or "the Company") (NASDAQ:FDMT) for violations of the securities laws. The investigation focuses on whether the Company

Investors Are Encouraged To Join The Schall Law Firm In An Inquiry Into Rapid7, Inc. For Possible Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Rapid7, Inc. ("Rapid7" or "the Company") (NASDAQ:RPD) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses

Investors Are Encouraged To Join The Schall Law Firm In An Inquiry Into Thoughtworks Holding Inc For Securities Law Violations

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Thoughtworks Holding, Inc. ("Thoughtworks" or "the Company") (NASDAQ:TWKS) for potential breaches of fiduciary duty on the part of its directors and management. The investigation

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Wolfspeed, Inc. For Possible Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Wolfspeed, Inc. ("Wolfspeed" or "the Company") (NYSE:WOLF) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Actinium Pharmaceuticals Inc For Possible Securities Fraud

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company") (NYSE American:ATNM) for violations of the securities laws. The investigation focuses on whether the Company issued false

The Schall Law Firm Is Looking Into Whether Customers Bancorp Inc Committed Securities Fraud And Investors With Losses Should Reach Out

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Customers Bancorp, Inc. ("Customers Bancorp" or "the Company") (NYSE:CUBI) for violations of the securities laws. The investigation focuses on whether the Company issued false

Sprinklr Inc Is Being Sued For Possible Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sprinklr, Inc. ("Sprinklr" or "the Company") (NYSE:CXM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the

Globus Medical, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Shareholder Participation

LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or "the Company") (NYSE:GMED) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

Scroll to Top